Novel targeted therapies: A challenge for drug development

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)S4
JournalClinical Lung Cancer
Volume5
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2003

Fingerprint

Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

@article{5951099a72e344f197b6e954d3f17956,
title = "Novel targeted therapies: A challenge for drug development",
author = "Belani, {Chandra P.}",
year = "2003",
month = "9",
doi = "10.3816/CLC.2003.s.008",
language = "English (US)",
volume = "5",
pages = "S4",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "SUPPL. 1",

}

Novel targeted therapies : A challenge for drug development. / Belani, Chandra P.

In: Clinical Lung Cancer, Vol. 5, No. SUPPL. 1, 09.2003, p. S4.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Novel targeted therapies

T2 - A challenge for drug development

AU - Belani, Chandra P.

PY - 2003/9

Y1 - 2003/9

UR - http://www.scopus.com/inward/record.url?scp=0142029047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142029047&partnerID=8YFLogxK

U2 - 10.3816/CLC.2003.s.008

DO - 10.3816/CLC.2003.s.008

M3 - Editorial

AN - SCOPUS:0142029047

VL - 5

SP - S4

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - SUPPL. 1

ER -